Neovacs Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Hugo Brugiere

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Hugo Brugiere's beloning veranderd ten opzichte van Neovacs's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Dec 31 2023n/an/a

-€9m

Sep 30 2023n/an/a

-€7m

Jun 30 2023n/an/a

-€5m

Mar 31 2023n/an/a

-€4m

Dec 31 2022n/an/a

-€4m

Sep 30 2022n/an/a

-€8m

Jun 30 2022n/an/a

-€11m

Mar 31 2022n/an/a

-€12m

Dec 31 2021n/an/a

-€12m

Sep 30 2021n/an/a

-€7m

Jun 30 2021n/an/a

-€3m

Mar 31 2021n/an/a

-€5m

Dec 31 2020€85k€75k

-€6m

Compensatie versus markt: Insufficient data to establish whether Hugo's total compensation is reasonable compared to companies of similar size in the French market.

Compensatie versus inkomsten: Insufficient data to compare Hugo's compensation with company performance.


CEO

Hugo Brugiere

no data

Tenure

€85,000

Compensatie

Mr. Hugo Brugiere, M. Sc., is Chairman and Chief Executive Officer of Boostheat SA. He has been Director of Pharnext S.C.A. (formerly known as Pharnext SA) since November 2022 and serves as its Chairman an...